Sign in
Taking people in United StatesNo phase

PRoducing Outcome Measures for OTP Quality Improvement

Key facts

Who runs it
RTI International
Where
Research Triangle Park, United StatesSee the site
Trial code
Status
Recruiting
People taking part
4,500 people, planned
Started
3 Oct 2025
Expected to end
1 Dec 2027
Type of study
Interventional, 3 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • Quality Measures (Audit and Feedback)
  • Quality Improvement (QI) Toolkit
  • External QI Facilitation
Record updated
27 August 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show the criterionShow less

Other criteria

  • Only BayMark OTPs are eligible for participation

Where in United States

  • RTI InternationalResearch Triangle Park, United StatesContact: Tami L Mark, PhDTaking people

About the trial

What the trial wants to find out

This study tests ways to help opioid treatment programs (OTPs) keep patients in care. Staying on methadone or buprenorphine is linked to better outcomes, yet many people leave treatment early. The project will compare two approaches that provide clinics with retention/outcome quality measures and a quality-improvement (QI) toolkit-either alone or with added facilitation-against usual care.

Read full original descriptionShow less

Forty-five BayMark OTPs in multiple states will be randomly assigned to one of three groups: (1) quality measures + QI toolkit; (2) quality measures + QI toolkit + external QI facilitation; or (3) usual care.

The primary outcome is 90-day retention in treatment, measured from OTP electronic health records and Medicaid claims. Secondary outcomes include emergency department visits, hospitalizations, overdoses, and mortality. Findings will identify practical, scalable strategies to improve patient retention in OTPs.

The 3 groups in the trial

  • Arm 1 - Title: Quality Measures + QI ToolkitTreatment being tested

    OTPs in this arm receive clinic-level quality measures (claims-based, case-mix-adjusted retention/outcome measures with benchmarks and peer comparisons) plus a self-guided QI toolkit (evidence summaries, change packages, templates, and examples) to support retention-focused practice changes. No external facilitation is provided

    Treatment: Quality Measures (Audit and Feedback) and Quality Improvement (QI) Toolkit

  • Arm 2 - Title: Quality Measures + QI Toolkit + External QI FacilitationTreatment being tested

    OTPs receive the quality measures and QI toolkit as in Arm 1 plus structured external QI facilitation based on the NIATx model. Facilitators coach an OTP change team, review data, and guide PDSA cycles to implement retention-focused improvements

    Treatment: Quality Measures (Audit and Feedback), Quality Improvement (QI) Toolkit, and External QI Facilitation

  • Arm 3 - Title: No Intervention: Usual CareNo study treatment, for comparison

    OTPs continue usual practice without access to the quality measures or QI toolkit and with no external facilitation during the study. Outcomes are assessed from EHR and Medicaid claims.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
Research to Foster an Opioid Use Disorder Treatment System Patients Can Count On: Project 2 - Producing Outcome Measures for OTP Quality Improvement
Record updated
27 August 2026